Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219017 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants
A Phase 1 study, sponsored by AbbVie.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT07219017 is a Phase 1 study that has completed, run by AbbVie. The registered enrollment target is 8 participants.
The verdict
NCT07219017, a Phase 1 study, has completed, sponsored by AbbVie.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is to assess the mass balance of oral ABBV-1354 in healthy adult male participants.
Interventions
- DRUG ABBV-1354
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2025-12-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07219017
The ClinicalTrials.gov registry entry for NCT07219017 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AbbVie, which has 526 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABBV-1354 is the first listed.
NCT07219017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07219017 about?
NCT07219017 is a clinical study titled "A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants". This study is to assess the mass balance of oral ABBV-1354 in healthy adult male participants.
What is the current status of trial NCT07219017?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2025-10-15. Estimated completion is 2025-12-09.
What interventions are being tested in trial NCT07219017?
The interventions under investigation include: ABBV-1354 (DRUG).
Who is sponsoring clinical trial NCT07219017?
This trial is sponsored by AbbVie, which has 526 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.